Congress is back in session with a loaded agenda for the lame duck period. One of the top issues the life sciences industry is tracking is the potential passage of the BIOSECURE Act. Speaker Johnson has signaled the House...more
11/20/2024
/ Biotechnology ,
Congressional Committees ,
Grandfathering Rules ,
Healthcare ,
Lame Duck Session ,
Legislative Agendas ,
Life Sciences ,
Pending Legislation ,
Proposed Legislation ,
Senate Committees ,
U.S. House
Six months into the fiscal year, Congress has finally passed FY2024 appropriations. It was a painstaking process, which many expected to include policy victories that both sides could celebrate. Instead, the spring work...more
4/9/2024
/ Artificial Intelligence ,
Biotechnology ,
Congressional Committees ,
Coronavirus/COVID-19 ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicare ,
Mental Health ,
New Legislation ,
Pandemic ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Proposed Legislation ,
Telehealth ,
Transparency
Congressional Activity -
The challenges around addressing health concerns related to per- and polyfluoroalkyl substances (PFAS) are immense. The Environmental Protection Agency (EPA) states that PFAS are widely used, long...more
On July 27, 2023, House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Ranking Member Frank Pallone, Jr., (D-NJ), along with Senate Health, Education, Labor, and Pensions (HELP) Committee Chair Bernie...more
On the heels of a January 2023 statement released by the FDA expressing the need for a new regulatory pathway for cannabidiol products, two CBD-related bills were reintroduced in the House of Representatives on March 17,...more